findmyKOL
Clinical trialNCT05538208RecruitingPhase 2Interventional

The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study

SponsorChildren's Hospital Medical Center, CincinnatiEnrollment105Lupus Nephritis
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The study is a 1-year 2-part double-blinded placebo controlled 2-arm clinical trial. Treatment arms are (1) MMF dosed as per body-surface area (MMFBSA; 600mg/m2 body surface area per dose about every 12 hours) and (2) pharmacokinetically-guided precision-dosing of MMF (MMFPK; MMF dosed twice daily to achieve an area under the concentration-time curve (AUC0-12h) of MPA \>60-70 mg\*h/L. The study goal is to determine the safety and efficacy of MMFPK compared to MMFBSA for the treatment of proliferative LN in subjects 8 to \<21 years.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of California, San Francisco

    San Francisco, California, United States

    Emily von Scheven, M.D., M.A.S.
    Recruiting
  • Children'S Hospital Colorado

    Aurora, Colorado, United States

    Katharine Moore, MD
    Recruiting
  • Emory Children'S Center

    Atlanta, Georgia, United States

    Larry Greenbaum, MD, MPH
    Recruiting
  • Ann & Robert H. Lurie Children'S Hospital of Chicago

    Chicago, Illinois, United States

    Pooja Patel, DO
    Recruiting
  • University of Chicago Medicine- Comer Children'S

    Chicago, Illinois, United States

    Coughi Edens, MD
    Recruiting
  • Washington University in St. Louis School of Medicine

    St Louis, Missouri, United States

    Brian Stotter, MD
    Recruiting
  • Hackensack University Medical Center

    Hackensack, New Jersey, United States

    Anna Carmela Gironella, MD
    Recruiting
  • Children'S Hospital at Montefiore

    New York, New York, United States

    Beatrice Goilav, MDDawn Wahezi, MD
    Recruiting
  • Hospital for Special Surgery

    New York, New York, United States

    Karen Onel, MD
    Recruiting
  • University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina, United States

    Eveline Wu, MDLaura Cannon, MD
    Recruiting
  • Akron Children'S Hospital

    Akron, Ohio, United States

    Kathryn Cook, DO
    Recruiting
  • Cincinnati Children'S Hospital Medical Center

    Cincinnati, Ohio, United States

    Recruiting
  • University Hospitals Cleveland Medical Center

    Cleveland, Ohio, United States

    R. Ezequiel Borgia, M.D M.S
    Recruiting
  • Nationwide Children'S Hospital

    Columbus, Ohio, United States

    Stacy Ardoin, M.D., M.S.
    Recruiting
  • Medical University of South Carolina

    Charleston, South Carolina, United States

    Natasha Ruth, M.D., M.S.
    Recruiting
  • Baylor College of Medicine Pediatric Immunology Allergy Rheumatology

    Houston, Texas, United States

    Marietta DeGuzman, MD
    Recruiting
  • University of Utah

    Salt Lake City, Utah, United States

    Aimee Hersh, MD
    Recruiting
  • Seattle Children'S Hospital/university of Washington

    Seattle, Washington, United States

    Kristen Hayward, MD, MS
    Recruiting
  • Children'S Wisconsin/medical College of Wisconsin

    Milwaukee, Wisconsin, United States

    Ellen Cody, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
7 Jun 2024
Primary completion
31 Jul 2026
Completion
31 Jan 2027
Last update posted
18 Mar 2026
Registered enrollment
105
Registry id
NCT05538208

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.